Stop accepting guesswork about women’s health. Start demanding answers. Millions of women enter perimenopause, a phase shrouded in confusion and uncertainty. Do you know a woman struggling to understand her changing body, battling unpredictable symptoms, forced to guess what is happening to her? Heidi Davis, CEO and Co-Founder of PERI, understands this frustration intimately. She does not offer vague advice; she delivers data. PERI, the company she built, provides a groundbreaking wearable device, a tool to track perimenopause symptoms objectively, ending the era of guesswork. Davis does not just sell a product; she champions a revolution in women’s health, grounded in concrete data and undeniable clarity.
Must women navigate perimenopause blinded by uncertainty? Are hot flushes, night sweats, and anxiety simply mysteries to endure? Is personalized management of symptoms just a hopeful aspiration? Heidi Davis rejected this status quo. She witnessed the lack of objective data surrounding perimenopause. She saw the confusion and frustration it caused women. She acted. She founded PERI to banish guesswork, empower women with knowledge, to deliver personalized management plans based on real data, not vague estimations. This is not just about easing symptoms; it is about restoring control and understanding.
From Molecular Insight to Wearable Breakthrough: Data, Not Guesswork, for Women’s Health
Heidi Davis did not stumble into women’s health. Her path is rooted in rigorous scientific training. With an academic background in nutrition and molecular medicine, she brings a deep understanding of the body’s complexities. Chronic disease prevention and treatment became her passion. For years, she developed new targets for health solutions using Artificial Intelligence. This is not just theoretical knowledge; it is practical expertise in applying cutting-edge science to health challenges.
Davis saw a glaring gap in women’s health: perimenopause. Women lacked objective data about their own bodies during this significant life transition. Symptoms varied wildly, and management plans relied on subjective reporting and often ineffective guesswork. Davis recognized an opportunity to apply her scientific expertise to fill this void. She did not see a niche market; she saw a profound unmet need, a chance to empower millions.
In 2021, PERI emerged. Davis, partnering with scientist Donal O’Gorman, co-founded the company. Their mission was clear: create a wearable device that accurately tracks perimenopause symptoms, providing women with objective data. This is not just another health tracker; it is a device specifically designed for perimenopause, focusing on the unique symptoms women experience. They did not aim to create a generic gadget; they aimed to build a targeted solution to a specific problem.
PERI’s approach is data-driven. The wearable device collects raw data. AI-enabled technology transforms this data into symptom information. The companion app presents this information to users, providing insights into hot flashes, night sweats, anxiety levels, and other key indicators. This is not just symptom logging; it is objective measurement, replacing subjective guesswork with concrete data. Davis and O’Gorman consulted over 500 women to inform device design. This is not technology built in isolation; it is user-centered innovation, directly addressing women’s needs and experiences.
From Start-Up to Scale-Up: Awards, Funding, and Market Validation
Heidi Davis did not build PERI in secret. She actively sought validation and support. Enterprise Ireland recognized PERI’s potential early on. They awarded Davis the High-Potential Start-Up (HPSU) Founder of the Year award in 2024. This was not just a trophy; it was recognition from peers and industry experts, affirming PERI’s promise and Davis’s leadership. This award highlighted Davis’s commitment and the potential of PERI to become a world-class company.
Securing funding became a critical responsibility. Peri successfully raised €1.4 million in initial funding. This was not easy money; it was earned through demonstrating PERI’s value proposition and Davis’s persuasive vision. Peri then launched a €1 million funding round to scale production and reach consumers. This continuous fundraising effort reflects Davis’s dedication to growth and her ability to attract investment in PERI’s mission.
Davis credits Enterprise Ireland with providing crucial support. They offered mentorship, guidance on market entry, regulatory requirements, and IP strategy. This support was not just advisory; it was instrumental in helping PERI navigate the complex path from concept to commercialization. Enterprise Ireland’s support helped PERI secure its first patent. This patent is not just a piece of paper; it is protection for PERI’s innovation, safeguarding its technology and market position.
Peri Wearable: Objective Data, Personalized Management, Real Power
The PERI device is not cumbersome or intrusive. It is a discreet wearable, fitting neatly under the breast, designed for comfort and continuous wear. The adhesive keeps the device in place for seven to ten days, even during showering or swimming. This is not a device that disrupts daily life; it integrates seamlessly into it, collecting data passively, and unobtrusively.
The Peri wearable tracks perimenopause symptoms objectively, alongside lifestyle and sleep data. This is not just symptom tracking in isolation; it is holistic data collection, providing a comprehensive picture of a woman’s health during perimenopause. The connected app guides users through perimenopause, providing information needed to create personalized management plans. This is not just data dumping; it is guided support, helping women interpret their data and take informed action.
The device uses four sensors to transform raw data into actionable symptom information. This is not based on subjective questionnaires; it is objective sensor technology, that measures physiological changes directly. The app delivers specific information on hot flushes, night sweats, and anxiety levels, among other symptoms. This is not vague symptom descriptions; it is precise, symptom-specific data, enabling targeted management strategies.
Heidi Davis: Leading Women to Data-Driven Empowerment
Heidi Davis is not just a CEO; she is a leader driven by purpose. She identified a significant gap in women’s health and acted decisively to fill it. Her leadership is characterized by a commitment to scientific rigor, user-centric design, and data-driven solutions. This is not leadership based on intuition alone; it is leadership grounded in evidence and empathy.
Davis’s vision extends beyond simply selling a product. Her ultimate aim is global: bring PERI to women worldwide. She seeks to empower women globally to live healthier, more productive lives by taking control of their perimenopause journey. This is not just about business growth; it is about global impact, improving the lives of millions of women. She views PERI’s mission as creating a more equitable world. This is not just about a health device; it is about societal change, redefining how humanity understands, talks about, and treats perimenopause.
Heidi Davis did not accept the uncertainty and guesswork surrounding perimenopause. She challenged the status quo. She built PERI to provide data, clarity, and personalized management. Are you ready to end the guessing game? Are you ready to empower yourself, or the women you know, with objective data and real answers about perimenopause? Heidi Davis and PERI offer you not just hope, but a tangible solution. Stop guessing. Start knowing. The future of perimenopause management is here, on your body, thanks to the leadership of Heidi Davis.
Also Read: Innovators in Neuromodulation: Transforming Mental Wellness and Sleep, 2025
